Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ <scp>Juvenile‐Onset</scp> Dermatomyositis
Matthew A. Sherman(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Livia Casciola‐Rosen(Johns Hopkins University), Qingyuan Yang(Shanghai Jiao Tong University), Andrew L. Mammen(Malaysian Society of Nephrology), Willy A. Flegel(National Institutes of Health Clinical Center), Laura Gutierrez‐Alamillo(Johns Hopkins University), Katherine Pak(National Institutes of Health), Lisa G. Rider(National Cancer Institute)
Cited by 6
Related Papers
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367
Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction
|Arthritis & Rheumatism|2005|345
Molecular Basis of Weak D Phenotypes
|Blood|1999|336